NCT06935825View on ClinicalTrials.gov

Respiratory Muscles in End-stage Lung Disease: Pathophysiological Processes & Clinical Consequences

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

April 1, 2029

Study Completion Date

September 1, 2029

Conditions
COPD
Trial Locations (4)

Unknown

Amsterdam University Medical Center, Amsterdam

University Medical Center Groningen, Groningen

Radboud University Medical Center, Nijmegen

Erasmus Medical Center, Rotterdam

Sponsors

Collaborators (1)

Erasmus Medical Center
All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

collaborator

Amsterdam UMC, location VUmc

OTHER

collaborator

Radboud University Medical Center

OTHER

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

University Medical Center Groningen

OTHER

NCT06935825 - Respiratory Muscles in End-stage Lung Disease: Pathophysiological Processes & Clinical Consequences | Biotech Hunter | Biotech Hunter